logo

For the Inventor, By the Inventor

Taipei, Taiwan

Pei-wen Hsiao

This inventor holds 9 USPTO granted patents and 2 published patent applications. Top assignee: Academia Sinica. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pei-wen Hsiao. Retrieved from https://idiyas.com/inventor/pei-wen-hsiao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 77.8

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal9 out of 726 
 
Academia Sinica
 patents

Years Active: 2013-2025

Loading Chart...
9 patents (USPTO):Explore Patents
1. 12359259 - Biomarkers for predicting prostate cancer progression (2025-07-15),
2. 11096977 - Development of a standardized and effect-optimized herbal extract ofand its use for treating disease (2021-08-24),
3. 10603346 - Development of a standardized and effect-optimized herbal extract ofand its use for treating disease (2020-03-31),
4. 10391163 - Bird flu vaccine combination comprising virus-like particles and novel adjuvants (2019-08-27),
5. 9795666 - High-yield transgenic mammalian expression system for generating virus-like particles (2017-10-24),
6. 9144591 - Transcription modulator compositions (2015-09-29),
7. 8980281 - High-yield transgenic mammalian expression system for generating virus-like particles (2015-03-17),
8. 8597701 - Transcription modulator compositions (2013-12-03),
9. 8519007 - Use certain diterpene compounds in the treatment of androgen receptor-associated diseases (2013-08-27),

Title: Pei-wen Hsiao: Innovator in Cancer Research and Herbal Medicine

Introduction

Pei-wen Hsiao is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the fields of cancer research and herbal medicine, holding a total of 9 patents. His work focuses on developing innovative solutions for predicting cancer progression and treating androgen-stimulated disorders.

Latest Patents

One of Hsiao's latest patents involves biomarkers for predicting prostate cancer progression. This invention relates to biomarkers, methods, and assay kits designed to predict prognosis and monitor the progression of prostate cancer. The biomarkers include gene products such as core 1 beta-3-galactosyltransferase (C1GALT1) and ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1), along with their saccharide substrates/products and galectin-4 gene products. Another notable patent is focused on the development of a standardized and effect-optimized herbal extract for treating diseases. This composition includes a standardized extract and outlines methods for treating androgen-stimulated disorders.

Career Highlights

Hsiao is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has allowed him to explore various innovative approaches in his field. His research has garnered attention for its potential impact on cancer treatment and herbal medicine.

Collaborations

Hsiao has collaborated with notable colleagues, including Chin-Hsien Tsai and Shih-Chuan Hsieh. These collaborations have contributed to the advancement of research in their respective fields.

Conclusion

Pei-wen Hsiao's contributions to cancer research and herbal medicine highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing scientific knowledge and developing practical solutions for pressing medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…